Literature DB >> 20045538

Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity.

Sadanori Okada1, Chisayo Kozuka, Hiroaki Masuzaki, Shintaro Yasue, Takako Ishii-Yonemoto, Tomohiro Tanaka, Yuji Yamamoto, Michio Noguchi, Toru Kusakabe, Tsutomu Tomita, Junji Fujikura, Ken Ebihara, Kiminori Hosoda, Hiroshi Sakaue, Hiroyuki Kobori, Mira Ham, Yun Sok Lee, Jae Bum Kim, Yoshihiko Saito, Kazuwa Nakao.   

Abstract

Adipose tissue expresses all components of the renin-angiotensin system including angiotensinogen (AGT). Recent studies have highlighted a potential role of AGT in adipose tissue function and homeostasis. However, some controversies surround the regulatory mechanisms of AGT in obese adipose tissue. In this context, we here demonstrated that the AGT messenger RNA (mRNA) level in human subcutaneous adipose tissue was significantly reduced in obese subjects as compared with nonobese subjects. Adipose tissue AGT mRNA level in obese mice was also lower as compared with their lean littermates; however, the hepatic AGT mRNA level remained unchanged. When 3T3-L1 adipocytes were cultured for a long period, the adipocytes became hypertrophic with a marked increase in the production of reactive oxygen species. Expression and secretion of AGT continued to decrease during the course of adipocyte hypertrophy. Treatment of the 3T3-L1 and primary adipocytes with reactive oxygen species (hydrogen peroxide) or tumor necrosis factor alpha caused a significant decrease in the expression and secretion of AGT. On the other hand, treatment with the antioxidant N-acetyl cysteine suppressed the decrease in the expression and secretion of AGT in the hypertrophied 3T3-L1 adipocytes. Finally, treatment of obese db/db mice with N-acetyl cysteine augmented the expression of AGT in the adipose tissue, but not in the liver. The present study demonstrates for the first time that oxidative stress dysregulates AGT in obese adipose tissue, providing a novel insight into the adipose tissue-specific interaction between the regulation of AGT and oxidative stress in the pathophysiology of obesity. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045538      PMCID: PMC2891233          DOI: 10.1016/j.metabol.2009.11.016

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  50 in total

Review 1.  Role of oxidative modifications in atherosclerosis.

Authors:  Roland Stocker; John F Keaney
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

2.  An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.

Authors:  Muneya Fujimoto; Hiroaki Masuzaki; Tomohiro Tanaka; Shintaro Yasue; Tsutomu Tomita; Kayoko Okazawa; Junji Fujikura; Hideki Chusho; Ken Ebihara; Tatsuya Hayashi; Kiminori Hosoda; Kazuwa Nakao
Journal:  FEBS Lett       Date:  2004-10-22       Impact factor: 4.124

3.  Angiotensinogen gene expression in 3T3-L1 cells.

Authors:  J A Saye; L A Cassis; T W Sturgill; K R Lynch; M J Peach
Journal:  Am J Physiol       Date:  1989-02

Review 4.  Transcriptional regulation of hepatic angiotensinogen gene expression by the acute-phase response.

Authors:  D Ron; A R Brasier; J F Habener
Journal:  Mol Cell Endocrinol       Date:  1990-12-21       Impact factor: 4.102

5.  Oxidative stress is associated with adiposity and insulin resistance in men.

Authors:  Hideki Urakawa; Akira Katsuki; Yasuhiro Sumida; Esteban C Gabazza; Shuichi Murashima; Kohei Morioka; Noriko Maruyama; Nagako Kitagawa; Takashi Tanaka; Yasuko Hori; Kaname Nakatani; Yutaka Yano; Yukihiko Adachi
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

6.  Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension.

Authors:  Carine M Boustany; Kalyani Bharadwaj; Alan Daugherty; David R Brown; David C Randall; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-10       Impact factor: 3.619

7.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  Circulating versus local renin-angiotensin system in cardiovascular homeostasis.

Authors:  V J Dzau
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

9.  Location and regulation of rat angiotensinogen messenger RNA.

Authors:  L A Cassis; J Saye; M J Peach
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

10.  Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes.

Authors:  S C Frost; M D Lane
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

View more
  13 in total

1.  Low-fat dairy, but not whole-/high-fat dairy, consumption is related with higher serum adiponectin levels in apparently healthy adults.

Authors:  Kaijun Niu; Yoritoshi Kobayashi; Lei Guan; Haruki Monma; Hui Guo; Yufei Cui; Atsushi Otomo; Masahiko Chujo; Ryoichi Nagatomi
Journal:  Eur J Nutr       Date:  2012-05-31       Impact factor: 5.614

2.  Polymorphism in miR-31 and miR-584 binding site in the angiotensinogen gene differentially influences body fat distribution in both sexes.

Authors:  Jan Machal; Jan Novak; Renata Hezova; Filip Zlamal; Anna Vasku; Ondrej Slaby; Julie Bienertova-Vasku
Journal:  Genes Nutr       Date:  2015-08-26       Impact factor: 5.523

Review 3.  Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT).

Authors:  Claudia Agabiti-Rosei; Anna Paini; Carolina De Ciuceis; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Damiano Rizzoni
Journal:  Curr Hypertens Rep       Date:  2018-05-07       Impact factor: 5.369

Review 4.  PVAT: an important guardian of the cardiovascular system.

Authors:  Xiuying Liang; Yan Qi; Fan Dai; Jingya Gu; Wenjuan Yao
Journal:  Histol Histopathol       Date:  2020-02-21       Impact factor: 2.303

5.  Maternal separation-induced increases in vascular stiffness are independent of circulating angiotensinogen levels.

Authors:  Timothy M Mahanes; Margaret O Murphy; An Ouyang; Frederique B Yiannikouris; Bradley S Fleenor; Analia S Loria
Journal:  J Appl Physiol (1985)       Date:  2020-05-14

6.  Longer duration of obesity is associated with a reduction in urinary angiotensinogen in prepubertal children.

Authors:  Manuela Morato; Liane Correia-Costa; Teresa Sousa; Dina Cosme; Franz Schaefer; José Carlos Areias; António Guerra; Alberto Caldas Afonso; Henrique Barros; Ana Azevedo; António Albino-Teixeira
Journal:  Pediatr Nephrol       Date:  2017-03-23       Impact factor: 3.714

7.  Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study).

Authors:  Hiroyuki Kobori; Maki Urushihara; Ji H Xu; Gerald S Berenson; Luis Gabriel Navar
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

8.  Role of H(2)O(2) in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II.

Authors:  T Sousa; S Oliveira; J Afonso; M Morato; D Patinha; S Fraga; F Carvalho; A Albino-Teixeira
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

9.  Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Sean Thatcher; Richard Charnigo; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

10.  Metabolic remodeling of white adipose tissue in obesity.

Authors:  Timothy D Cummins; Candice R Holden; Brian E Sansbury; Andrew A Gibb; Jasmit Shah; Nagma Zafar; Yunan Tang; Jason Hellmann; Shesh N Rai; Matthew Spite; Aruni Bhatnagar; Bradford G Hill
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-10       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.